Back from Egypt
Not long ago Newsweek bamboozled me into buying an on-line
subscription. For most news items they
are far inferior to the Economist, but they do seem to devote a generous amount
of time to health issues. I say this on
the basis of insufficient evidence; what drew me to them in the first place is
a special issue on cancer, now or recently on the newsstands. Here is an example of what you will find in
that issue:
You would do well to read this article. It examines the economics of developing drugs
for children with cancer, which is made unprofitable by the fact that cancer in
children is (blessedly) rare. Apparently
some progress is being made, but the hill to climb is very steep. As noted in the article, the average cost of
developing a new drug and bringing it to market is $1.7 billion.
The Web address for the whole special issue is:
Be careful and avoid being bamboozled.
No comments:
Post a Comment